ASCO GUIDELINES Bundle

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475462

Contents of this Issue

Navigation

Page 1 of 5

Key Points ➤ It is estimated that there will be 22,530 new cases of ovarian cancer diagnosed in 2019 in the United States and, in spite of advances in treatment, an estimated 13,980 women will die from the disease. ➤ Ovarian cancer ranks fifth in cancer deaths among women. ➤ Approximately 25% of all ovarian cancers are caused by a heritable genetic condition. ➤ Many medical societies recommend genetic testing for all women diagnosed with ovarian cancer, yet only about 30% of women undergo any genetic testing.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer